Skip to main content

MONDAY, Jan. 17, 2022 (HealthDay News) -- You've gotten vaccinated. You've gotten boosted. You wear your mask, maintain social distancing, wash your hands — you do everything you've been asked to do to protect yourself and others.

MONDAY, Jan. 17, 2022 (HealthDay News) -- The latest shipment of 1.1 million COVID-19 vaccines to Rwanda this weekend signaled a noteworthy achievement: The COVAX program, a United Nations-backed program providing poorer countries with vaccines, has now shipped one billion of the doses to combat the coronavirus in 144 countries.

  • Updated
  • Comments

MONDAY, Jan. 17, 2022 (American Heart Association News) -- Surgeons recently transplanted a genetically modified pig's heart into a man with life-threatening heart failure. The successful surgery became a medical first that is raising hopes of a new, viable alternative for people at risk of dying before limited human cadaver hearts become available and for those too sick or ineligible for human heart transplantation.

MONDAY, Jan. 17, 2022 (HealthDay News) -- Residents of nursing homes have been a particularly at-risk group throughout the pandemic, and the advent of the fast-spreading Omicron variant has them facing another wave of infections and deaths, new data shows.

Are you among the 'vaxxed and done'? As Americans enter the third year of the COVID-19 pandemic, many are willing to keep getting boosted -- but they also want to reap the rewards of their good behavior rather than maintain masking and other measures that protect the unvaccinated. Read more

MONDAY, Jan. 17, 2022 (HealthDay News) -- Astronauts can develop a condition called space anemia because their bodies destroy more red blood cells than normal when in space, a groundbreaking study shows.

MONDAY, Jan. 17, 2022 (HealthDay News) -- Flu vaccines protect children against serious illness, even when the vaccine doesn't match the circulating flu virus, according to a new study that reinforces the importance of flu shots.

  • Updated
  • Comments

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 10 to 14, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- Insurance coverage for acupuncturist visits increased from 2010 to 2019, but most costs are paid out of pocket, according to a research letter published online Jan. 12 in JAMA Network Open.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- The nomination of former U.S. Food and Drug Administration head Robert Califf, M.D., to again lead the agency now heads to the full Senate for a vote, after a Senate committee on Thursday voted 13-8 for approval.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- The Janus kinase (JAK) inhibitor baricitinib is strongly recommended for patients with severe or critical COVID-19, and sotrovimab is conditionally recommended for nonsevere COVID-19, according to the updated World Health Organization living guideline on drugs for COVID-19, published online Jan. 13 in The BMJ.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- Full COVID-19 vaccination, including third doses and/or boosters, is recommended for all patients with cancer, with a strong preference for mRNA vaccines, according to expert consensus recommendations published by the National Comprehensive Cancer Network (NCCN).

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- A comprehensive approach is recommended for management of cardiovascular risk factors among patients with type 2 diabetes (T2D), according to an American Heart Association scientific statement published online Jan. 10 in Circulation.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- The severity of certain menopause symptoms is associated with worse cognitive performance among rural women, according to a study published online Jan. 10 in Menopause.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- The prevalence of colorectal neoplasia observed among younger outpatients undergoing colonoscopies supports the recommendation to lower the screening age for colorectal cancer (CRC) to age 45 years, according to a study published online Jan. 4 in Gastroenterology.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- Secondhand nicotine vape exposure at home is associated with increased odds of bronchitic symptoms and shortness of breath among young adults, according to a study published online Jan. 10 in Thorax.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- For patients with early Parkinson disease (PD), average regular overall physical activity levels over time are associated with slower deterioration of postural and gait stability, activities of daily living, and processing speed, according to a study published online Jan. 12 in Neurology.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- Approximately 3 percent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive youth tested in emergency departments experience severe outcomes within two weeks of their index visit, according to a study published online Jan. 11 in JAMA Network Open.

  • Updated
  • Comments

FRIDAY, Jan. 14, 2022 (HealthDay News) -- Primary care providers should make individual decisions whether to prescribe aspirin based on a benefit-to-risk ratio, not simply age, according to a review published online Dec. 24 in Family Medicine and Community Health.

Starting Saturday, many Americans can get at-home Covid-19 tests for free through their private insurance. CNN's Jacqueline Howard reports on what steps to take to get a rapid test at no cost through your insurance coverage.

FRIDAY, Jan. 14, 2022 (HealthDay News) -- For years, researchers have suspected that the Epstein-Barr virus, best known for causing mononucleois, might also play a role in triggering multiple sclerosis. Now a new study strengthens the case.

FRIDAY, Jan. 14, 2022 (HealthDay News) -- The nomination of former U.S. Food and Drug Administration head Dr. Robert Califf to again lead the agency now heads to the full Senate for a vote, after a Senate committee on Thursday voted 13-8 for approval.

Could the 'mono' virus be a cause of MS? Researchers have long suspected that the Epstein-Barr virus might play a role in multiple sclerosis, and now a new study strengthens the case. Researchers found the risk of developing MS shot up 32-fold after infection. Read more